PFSA · Profusa Inc
United States · RS rating 17 · As of 2026-11-03
| Price | 0.62 USD |
|---|---|
| 1-day change | -5.0% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 3 / 17 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 14 / 17 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | -180.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +97.8% |
| Market cap (USD) | $2.6M |